Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

被引:14
|
作者
Ji, Kun [1 ]
Ma, Jianling [1 ]
Wang, Liangmin [1 ]
Li, Niuniu [1 ]
Dong, Shangjuan [1 ]
Shi, Liqing [1 ]
机构
[1] Beijing Univ Tradit Chinese Med, Dongfang Hosp, Dept Resp Med, Beijing 100078, Peoples R China
基金
中国国家自然科学基金;
关键词
EPIDEMIOLOGY; SURVIVAL; TRIAL;
D O I
10.1155/2020/1752387
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis. Methods. Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM. Results. A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = - 0.51, 95% CI - 0.70 to - 0.22, p < 0.001). Subgroup analysis of different study durations (3 months, >= 6 months) and comparison models (TCM vs. WM, TCM+ WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27-1.60, p = 0.352). *ere was no obvious publication bias, and the pooled results were stable according to sensitivity analysis. Conclusion. To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] The efficacy of traditional Chinese medicine for treatment of dry eye symptom: a meta-analysis
    Xu, Wen
    Gao, Weiping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (05): : 7945 - 7951
  • [42] Meta-analysis of Clinical Efficacy of Traditional Chinese Medicine in the Treatment of Aplastic Anemia
    Le-Min Xia
    Le-Le Cui
    Yi-Ling Jiang
    Zheng Qin
    Mei-Hong Luo
    World Journal of Traditional Chinese Medicine, 2017, 3 (04) : 46 - 50
  • [43] Effectiveness and safety of traditional Chinese medicine on stable chronic obstructive pulmonary disease: A systematic review and meta-analysis
    Wang Haifeng
    Zhang Hailong
    Li Jiansheng
    Yu Xueqing
    Li Suyun
    Li Bin
    Xie Yang
    Bai Yunping
    COMPLEMENTARY THERAPIES IN MEDICINE, 2015, 23 (04) : 603 - 611
  • [44] Efficacy and safety of traditional Chinese herbal medicine in the treatment of threatened abortion A protocol for systematic review and meta-analysis
    Zeng, Pengfei
    Zhou, Hang
    Guo, Pei
    Xia, Wanting
    Huang, Jinzhu
    Zeng, Qian
    MEDICINE, 2021, 100 (05) : E23288
  • [45] Efficacy and safety of traditional Chinese medicine yangxin anshen therapy for insomnia A protocol of systematic review and meta-analysis
    Li, Feizhou
    Wang, Xuanxuan
    Song, Ziyu
    Liu, Ling
    Zhang, Tong
    Chen, Yanhua
    Wang, Ping
    MEDICINE, 2019, 98 (37)
  • [46] Efficacy and safety of Danlou tablets in traditional Chinese medicine for coronary heart disease: a systematic review and meta-analysis
    Mao, WeiLi
    Lu, Peng
    Wan, Renhong
    Mao, Kaili
    Lv, Yanzhu
    Hu, Jie
    Fu, Zhenling
    Wang, Jun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [47] Efficacy and safety of retention enema with traditional Chinese medicine for ulcerative colitis: A meta-analysis of randomized controlled trials
    Yan, Zi-xing
    Liu, You-mei
    Ma, Teng
    Xu, Meng-jun
    Zhang, Xiao-bin
    Zha, Xiao-jing
    Yang, Jian-hua
    Jiang, Peng
    Chen, Xi
    Lin, Zhen-wen
    Wu, Yan-hua
    Zu, Ruo-zhen
    Lin, Wei-ran
    Lin, Xiao-ying
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2021, 42
  • [48] Efficacy and safety of traditional Chinese medicine on thromboembolic events in patients with atrial fibrillation: A systematic review and meta-analysis
    Wang, Zhangsheng
    Tang, Zeng
    Zhu, Wenqing
    Ge, Lei
    Ge, Junbo
    COMPLEMENTARY THERAPIES IN MEDICINE, 2017, 32 : 1 - 10
  • [49] Efficacy and safety of traditional Chinese patent medicine on carotid artery atherosclerosis in adults A network meta-analysis protocol
    Sun, Huiqing
    Qu, Wei
    Chen, Guangjia
    Sun, Xiaonan
    Zhang, Deqing
    Shao, Shichuan
    MEDICINE, 2021, 100 (03) : E24406
  • [50] Efficacy and safety of traditional Chinese medicine for the treatment of influenza A (H1N1): A meta-analysis
    Li, Jiang-Hong
    Wang, Re-Qin
    Guo, Wen-Jie
    Li, Juan-Sheng
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2016, 79 (05) : 281 - 291